Explorer les evidences

7,4 %Of the 231 cases of histoplasmosis reported from Nigeria, 17 (7.4%) were from South East Nigeria.

Nigeriahistoplasmosispublié 2023The Nigerian postgraduate medical journalPubMeddocument de 11 observations

2 %The southeastern region of Nigeria had the lowest pooled prevalence of sickle cell disease at 2.0%.

Nigeriadrépanocytosepublié 2025Systematic reviewsPubMeddocument de 7 observations

11,1 %A dose-dependent but reversible leucopenia was observed among six children (11.1%) during hydroxyurea therapy.

Nigeriadrépanocytosepublié 2020Journal of tropical pediatricsPubMeddocument de 4 observations

17 %Overall 211 children (17%) with delay in clearance subsequently failed therapy.

Nigeriapaludismeobservé 1996–2008publié 2010Malaria journaleurope_pmcdocument de 7 observationsDOI 10.1186/1475-2875-9-53

0,9 odds_ratio_per_1_percent_HbFThe odds of having LVSD decreased by 0.9 for every 1% increase in HbF level.

Nigeriadrépanocytosepublié 2026BMC cardiovascular disordersPubMeddocument de 6 observations

33,3 %Only one-third of the participants were diagnosed within the first year of age.

Nigeriadrépanocytosepublié 2022Annals of medicinePubMeddocument de 6 observations

118 genomes118 MPXV genomes were sequenced from cases in Nigeria and Cameroon between 2018 and 2023.

Cameroun · Nigeriampoxobservé 2018 to 2023publié 2025Natureeurope_pmcdocument de 5 observations

8,8 g/dLHemoglobin (Hb) in steady state subjects was 8.8 ± 0.9.

Nigeriadrépanocytosepublié 2022The Pan African medical journalPubMeddocument de 14 observations

52 %In the 2022 global mpox outbreak, 52% of confirmed mpox cases with known HIV status were people living with HIV.

Nigeriampoxobservé 2022publié 2023AIDS research and human retrovirusesPubMeddocument de 4 observations

84 414 casesAs of December 2020, approximately 84,414 cases of COVID-19 have been identified in Nigeria.

NigeriaCOVID-19observé December 2020HAL · Unilimdocument de 63 observations

36 %Among breast cancer patients undergoing chemotherapy in Delta State, Nigeria, 36% experienced moderate symptom burden.

Nigeriacancer du seinpublié 2026The Pan African medical journalPubMeddocument de 5 observations

64,08 %Only 364 (64.08%) of the 568 patients had the required parameters for calculation of low-density lipoprotein cholesterol (LDL-C) by the Friedewald formula.

NigeriaVIH/sidaobservé 2018publié 2024Nigerian journal of clinical practicePubMeddocument de 7 observations

28,1 %The most prevalent mutant haplotypes in the study were ISGKAA (28.1%) and VAGKGS (41.8%).

Nigeriapaludismepublié 2022The Pan African medical journalPubMeddocument de 8 observations

37,9 %Prevalence of bacterial vaginosis was 37.9% among women living with HIV in Lagos, Nigeria.

Nigeriavaginose bactériennepublié 2025BMC women's healthPubMeddocument de 9 observations

1,4 %The prevalence of sickle cell trait in the general population of Nigeria is 1.4%.

Nigeriadrépanocytosepublié 2022The open AIDS journaleurope_pmcdocument de 3 observations

52,2 %Forty-seven (52.2%) participants have steady state haematocrit in the range of 21-25%.

Nigeriadrépanocytosepublié 2022Annals of medicinePubMeddocument de 6 observations

13,2 %High triglycerides were observed in 13.2% of participants in the Kabong community, Jos, north central Nigeria.

Nigeriahigh triglyceridesobservé 2017publié 2023West African journal of medicinePubMeddocument de 14 observations

3 casesThree mothers living with HIV had received HPV vaccination.

Nigeriainfection à HPVpublié 2026BMC public healthPubMeddocument de 8 observations

2,71 odds_ratioFive years or more duration of type 2 diabetes mellitus was associated with an odds ratio of 2.71 for masked hypertension.

Nigeriadiabète de type 2 · masked hypertensionpublié 2025Journal of human hypertensionPubMeddocument de 7 observations

6,7 heuresPour les cas originaires d’Asie, la clairance parasitaire est lente avec une baisse de 50 % du parasite en 6,7 heures en moyenne.

NigeriapaludismeHAL · Unilimdocument de 173 observations

38 yearsThe median age of the 3059 people living with HIV was 38 years.

NigeriaVIH/sidaobservé 2013 to 2021publié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations

Socioeconomic factors are strong determinants of breast cancer at a 1% level of significance.

Nigeriacancer du seinpublié 2022African journal of reproductive healthPubMeddocument de 5 observations

2,8 odds_ratioIndividuals living in conflict zones in Nigeria were about three times as likely to test positive for HIV (adjusted odds ratio = 2.80).

NigeriaVIH/sidaobservé 2018publié 2021Annals of global healthPubMeddocument de 12 observations

100 %After 1 year, program-implementation and maintenance rates were 100%.

Nigeriadrépanocytosepublié 2022Journal of pediatric hematology/oncologyPubMeddocument de 5 observations

55 %Human immunodeficiency virus (HIV) infection was present in 128 out of 232 (55%) of patients with serious adverse drug reactions in Nigeria.

NigeriaVIH/sidaobservé September 2004 to December 2016publié 2019Pharmaceutical medicinePubMeddocument de 11 observations